Chewy, Inc. Form 10-Q Summary
Reporting period: The filing covers the 13 and 26 weeks ended July 30, 2023, compared with the periods ended July 31, 2022. The request metadata says 2022 Q2, but the filing itself is for 2023 Q2.
Business context and key results
Chewy is a U.S. e-commerce retailer of pet products and services, including consumables, hardgoods and pet healthcare. Results below are in U.S. dollars; financial statement amounts are in millions unless otherwise noted.
| Metric | 13 weeks ended July 30, 2023 | Year-over-year change | 26 weeks ended July 30, 2023 | Year-over-year change |
|---|---|---|---|---|
| Net sales | $2,777.8 | +14.3% | $5,562.4 | +14.5% |
| Gross profit / margin | $786.8 / 28.3% | Margin +20 bps | $1,578.2 / 28.4% | Margin +60 bps |
| Operating income (loss) / margin | $(17.9) / (0.6%) | Prior-year income $21.7 | $6.1 / 0.1% | Prior-year income $40.5 |
| Net income / margin | $18.9 / 0.7% | Down 15.2% | $41.1 / 0.7% | Up 0.8% |
| Adjusted EBITDA / margin | $86.9 / 3.1% | Up 4.6%; margin down from 3.4% | $197.0 / 3.5% | Up 37.2%; margin up from 3.0% |
| Operating cash flow | $158.8 | Prior year $49.2 | $307.1 | Prior year $131.6 |
| Free cash flow, non-GAAP | $101.1 | Prior year $1.0 | $227.9 | Prior year $7.4 |
Basic and diluted GAAP EPS were $0.04 for the quarter, versus $0.05 a year earlier; first-half EPS was $0.10 in both years. Adjusted diluted EPS was $0.15 for the quarter and $0.35 for the first half. Adjusted measures are non-GAAP and exclude specified items, including share-based compensation; they should be considered alongside GAAP results.
Revenue, margins and operating trends
- Quarterly sales growth was driven by increased spending from new and existing customers and Autoship purchasing frequency. Consumables sales rose 17.0%; hardgoods rose 2.2%; other sales rose 11.4%.
- Active customers were 20.367 million, down 0.6%. Net sales per active customer rose 14.7% to $530. Autoship customer sales increased 18.1% to $2,097.4 million and represented 75.5% of sales, up from 73.1%.
- Gross margin improved as cost of goods sold grew more slowly than sales, reflecting fulfillment efficiencies and favorable sales mix; management also cited pricing strength for the first half.
- Quarterly operating expenses rose 21.7%, faster than sales. SG&A increased 19.8%, including higher facilities, fulfillment and share-based compensation costs; advertising and marketing rose 28.7% as Chewy invested in additional marketing channels.
Cash, liquidity and obligations
- At July 30, 2023, cash and cash equivalents were $457.1 million and marketable securities were $448.3 million, totaling $905.4 million. Cash increased $126.7 million from January 29, 2023.
- Chewy had no ABL Credit Facility borrowings and reported $749.6 million of borrowing capacity, subject to the borrowing base. The facility provides up to $800 million and matures August 27, 2026.
- Cash from operations for the first half was $307.1 million; capital expenditures were $79.2 million, primarily for fulfillment capacity and IT. Investing cash outflow also included net purchases of marketable securities.
- The balance sheet reported $2,539.4 million of total liabilities, including $1,999.4 million of current liabilities and $517.3 million of operating lease liabilities. The filing reports no outstanding ABL borrowings; lease obligations remain significant.
- Management said cash, marketable securities and available revolving credit should fund working capital, capital expenditures and contractual obligations for at least the next 12 months.
Material changes, unusual items and outlook
- Quarterly net income included $29.2 million of other income, principally a non-cash increase in the fair value of equity warrants. First-half other income was $20.4 million, including a $20.3 million warrant fair-value gain. These Level 3 valuations depend partly on unobservable assumptions.
- Quarterly GAAP operating results shifted from $21.7 million of operating income to a $17.9 million loss, even as gross margin improved, amid higher SG&A and marketing costs. First-half operating income fell to $6.1 million from $40.5 million.
- First-half share-based compensation expense was $114.5 million, versus $64.2 million a year earlier. Management identifies share-based compensation as recurring; it is excluded from certain non-GAAP measures.
- Management provided no specific financial guidance in the supplied filing text. It cited inflation, interest rates and changing customer behavior as ongoing uncertainties and said it is adapting logistics, supply chain and purchasing processes.
- IBM litigation remains pending: Chewy says it will defend against IBM’s renewed allegation concerning a patent and the appeal of prior rulings. The company stated it believes current legal matters are adequately accrued and does not expect them to have a material adverse effect, while noting outcomes are uncertain.
- The company reported no material changes to its previously disclosed risk factors or market-risk disclosures. Management concluded disclosure controls were effective at a reasonable assurance level.
Important facts for investors to verify
- Confirm the intended period: the supplied filing is the 10-Q for the quarter ended July 30, 2023, not 2022 Q2.
- Review whether sales-per-customer growth and Autoship momentum can persist while active customers remain slightly lower year over year.
- Track operating expense growth, especially marketing, fulfillment, facilities and recurring share-based compensation, against sales and gross-margin progress.
- Separate underlying operating performance from warrant fair-value gains and the company’s non-GAAP adjustments.
- Assess working-capital effects on cash flow, planned capital spending and the borrowing-base availability of the ABL facility.
- Monitor the IBM patent proceedings and the assumptions affecting the Level 3 equity-warrant valuation.